bluebird bio, Inc. Proceeds from Issuance Initial Public Offering
bluebird bio, Inc. reported Proceeds from Issuance Initial Public Offering of $109.77 million for the 1-month period ending 2014-07-31, per its 10-Q filed 2014-11-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2014-11-12
- bluebird bio, Inc. proceeds from issuance initial public offering for the quarter ending 2013-12-31 was -$51.00K.
- bluebird bio, Inc. proceeds from issuance initial public offering for the quarter ending 2013-09-30 was -$1.21M.
- bluebird bio, Inc. proceeds from issuance initial public offering for fiscal 2013 was $104.92M.
| Period end | Proceeds from Issuance Initial Public Offering 1 month | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|---|
| 2014-07-31 | $109.77M 10-Q · filed 2014-11-12 | ||||
| 2013-12-31 | -$51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-05 | -$1.26M derived: sum of 2 quarters · filed 2014-03-05 | $104.92M 10-K · filed 2014-03-05 | ||
| 2013-09-30 | -$1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $104.97M 10-Q · filed 2013-11-14 | |||
| 2013-06-30 | $106.18M 10-Q · filed 2014-08-12 | ||||
| 2013-06-24 | $104.92M 10-K · filed 2014-03-05 |